LigoCyte Pharmaceuticals
Latest round
- Series D
Last raised
- Jun 2012
Total raised
- $30M
Investors
- 7
About LigoCyte Pharmaceuticals
LigoCyte Pharmaceuticals Inc.LigoCyte Pharmaceuticals Inc. is engaged in developing advanced biotechnology solutions and specializes in innovative vaccine platforms. The company is headquartered in Bozeman, US.845 mn post-money.LigoCyte Pharmaceuticals Inc. specializes in the development of advanced biotechnology solutions, primarily focusing on novel therapeutic and diagnostic products. Their core offerings include innovative vaccine platforms designed to address various infectious diseases and immune-related conditions, leveraging proprietary technologies that enhance efficacy and safety profiles. The company aims to resolve critical challenges in healthcare by providing vaccines that are effective and scalable for mass production, thereby improving accessibility for diverse populations. These products target healthcare providers, pharmaceutical companies, and research institutions across North America and Europe, with expanding interests in the Asia-Pacific region.LigoCyte Pharmaceuticals Inc. operates on a revenue model that primarily hinges on strategic partnerships and collaborations with healthcare institutions and research organizations. The company engages in B2B transactions, providing its innovative vaccine solutions through direct contracts with healthcare providers and pharmaceutical companies. Revenue streams are generated through fixed-term agreements and milestone-based payments aligned with product development stages and successful deployment of their vaccine platforms. Pricing structures for their products are established through negotiations with partners, often reflecting the complexity and uniqueness of the technologies involved.LigoCyte Pharmaceuticals Inc. The company is targeting the Asia-Pacific region for expansion, with plans to enter this market by 2023.
Who invested in LigoCyte Pharmaceuticals
7 investors across 2 rounds
See all investors in LigoCyte Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LigoCyte Pharmaceuticals
Who invested in LigoCyte Pharmaceuticals?
LigoCyte Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LigoCyte Pharmaceuticals raised?
LigoCyte Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did LigoCyte Pharmaceuticals last raise money?
LigoCyte Pharmaceuticals's most recent round on record is a Series D, in Jun 2012.
What does LigoCyte Pharmaceuticals do?
LigoCyte Pharmaceuticals is a pharmaceuticals company.
Where is LigoCyte Pharmaceuticals headquartered?
LigoCyte Pharmaceuticals is headquartered in Bozeman, US.
Which VCs invest in companies like LigoCyte Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at LigoCyte Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like LigoCyte Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.